These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 24285378)

  • 1. Synthesis of [15, 16- ³H] beta-funaltrexamine.
    Filer CN; Seguin RJ
    J Labelled Comp Radiopharm; 2013 May; 56(5):310-1. PubMed ID: 24285378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu opiate active substances trefentanil and naloxonazine: tritiation at high specific activity.
    Ahern DG; Egan JA; Seguin RJ; Filer CN
    Appl Radiat Isot; 2005 Aug; 63(2):189-92. PubMed ID: 15927477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of selectively labeled histidine and its methylderivatives with deuterium, tritium, and carbon-14.
    Šamonina-Kosicka J; Kańska M
    J Labelled Comp Radiopharm; 2013 May; 56(6):317-20. PubMed ID: 24285411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on kinetics of [3H]beta-funaltrexamine binding to mu opioid receptor.
    Liu-Chen LY; Li SX; Tallarida RJ
    Mol Pharmacol; 1990 Feb; 37(2):243-50. PubMed ID: 2154672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphinan alkaloids labeled with tritium: synthesis and applications.
    Filer CN
    J Labelled Comp Radiopharm; 2013 Nov; 56(13):639-48. PubMed ID: 25196025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tritium labelling of dopaminergic ligands domperidone and (+/-)-7-hydroxy DPAT.
    Pounds S; Seguin RJ; Filer CN
    Appl Radiat Isot; 2005 Jan; 62(1):49-53. PubMed ID: 15498684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDV3100: Tritium labeling at high specific activity.
    Byon C; Chakravarty S; Filer CN; Jain R; Maniscalco MP
    Appl Radiat Isot; 2016 Feb; 108():35-37. PubMed ID: 26686973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tritiation of nonpeptide substance P antagonist CP-96,345 and its azido analogue. Synthetic and characterization details.
    Egan JA; Filer CN
    Appl Radiat Isot; 2003; 59(5-6):333-5. PubMed ID: 14622931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
    Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization in vivo of the novel opiate, beta-funaltrexamine.
    Ward SJ; Portoghese PS; Takemori AE
    J Pharmacol Exp Ther; 1982 Mar; 220(3):494-8. PubMed ID: 6121045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethyl-³H analogues of plant natural products: Biologically active proxy radioligands via vinyl group tritiation.
    Orphanos D; Filer CN
    Appl Radiat Isot; 2016 Jan; 107():203-205. PubMed ID: 26520478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosynthesis of [18F]3-acetylcyclofoxy: a high affinity opiate antagonist.
    Channing MA; Eckelman WC; Bennett JM; Burke TR; Rice KC
    Int J Appl Radiat Isot; 1985 Jun; 36(6):429-33. PubMed ID: 2993171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent labeling of mu opioid binding site by [3H]beta-funaltrexamine.
    Liu-Chen LY; Phillips CA
    Mol Pharmacol; 1987 Sep; 32(3):321-9. PubMed ID: 2823089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tritiation and characterization of several suicide substrate enzyme inactivators.
    Egan JA; Filer CN
    Appl Radiat Isot; 2014 Dec; 94():302-305. PubMed ID: 25305521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-[3H]funaltrexamine-labeled mu-opioid receptors: species variations in molecular mass and glycosylation by complex-type, N-linked oligosaccharides.
    Liu-Chen LY; Chen C; Phillips CA
    Mol Pharmacol; 1993 Oct; 44(4):749-56. PubMed ID: 8232225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY; Yang HH; Li S; Adams JU
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW; Liu-Chen LY
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex.
    Rothman RB; Bykov V; Mahboubi A; Long JB; Jiang Q; Porreca F; de Costa BR; Jacobson AE; Rice KC; Holaday JW
    Synapse; 1991 Jun; 8(2):86-99. PubMed ID: 1652797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, radiolabeling, and preliminary biological evaluation of [3H]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl)-piperazine, a potent antagonist radioligand for the P2X7 receptor.
    Romagnoli R; Baraldi PG; Pavani MG; Tabrizi MA; Moorman AR; Di Virgilio F; Cattabriga E; Pancaldi C; Gessi S; Borea PA
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5709-12. PubMed ID: 15482953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence.
    Rothman RB; Long JB; Bykov V; Jacobson AE; Rice KC; Holaday JW
    J Pharmacol Exp Ther; 1988 Nov; 247(2):405-16. PubMed ID: 2846819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.